๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Problems in the investigational study and clinical use of cancer immunotherapy

โœ Scribed by Michael E Osband; Susan Ross

Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
478 KB
Volume
11
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of cellular and cytokine adjuvants i
Use of cellular and cytokine adjuvants in the immunotherapy of cancer
โœ Salgaller, Michael L.; Lodge, Patricia A. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 2 views

Cellular and cytokine adjuvants, often immune effector cells and soluble factors, respectively, are supplemental and/or follow-up treatments of human origin for cancer patients who have unsatisfactory clinical responses to conventional chemotherapy, radiotherapy, and surgery. Since many human studie

Principles and use of anti-CTLA4 antibod
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
โœ Karl S Peggs; Sergio A Quezada; Alan J Korman; James P Allison ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 416 KB

Cytotoxic T lymphocyte antigen-4 has become recognized as one of the key negative regulators of adaptive immune responses, having a central role in the maintenance of peripheral tolerance and in shaping the repertoire of emergent T cell responses. Concurrent recognition of the potential importance o